Dr. Anna Kazmierczak, PT,DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 16 Sherwood Rd, Upper Saddle River, NJ 07458 Phone: 917-859-6549 Fax: 201-934-1241 |
Sharon George, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2 Ginkgo Court, Upper Saddle River, NJ 07458 Phone: 201-772-4622 |
Dr. Julie Ferraro, PT, DPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 59 Mill Glen Rd, Upper Saddle River, NJ 07458 Phone: 201-315-0376 |
Advanced Sports Pt Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2 Ginkgo Ct, Upper Saddle River, NJ 07458 Phone: 201-772-4622 |
Advanced Sports Pt One Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2 Ginkgo Ct, Upper Saddle River, NJ 07458 Phone: 201-772-4622 |
News Archive
BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that a Notice of Allowance has been issued by the United States Patent and Trademark Office (USPTO) for a patent claiming the composition of BL-7010, a novel polymer for the treatment of celiac patients.
In cath lab procedures, clearly visualizing complex vascular structures is crucial to making exams faster and easier. Toshiba will showcase a new 56-inch LCD monitor for the Infinix-i line at this year's Transcatheter Cardiovascular Therapeutics (TCT) annual conference, November 7-11, 2011, in San Francisco, Calif.
Alpha viruses, such as Sindbis virus, carry their genetic information on a single strand of RNA. On infection they use a protein, replicase, to produce double stranded RNA which is used as genetic material to make more viruses. However the body recognizes dsRNA as foreign, and infected cells initiate an immune response.
"I can't help worrying that, as donors slap themselves on the back over their generosity [shown through pledges to the GAVI Alliance] …, their feelgood factor will turn into a warm glow of satisfaction at having played out their part. Problem solved," Sarah Boseley writes on the Guardian's "Global Health Blog."
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
› Verified 6 days ago